ECM
AURA icon

ExodusPoint Capital Management’s Aura Biosciences AURA Stock Holding History

ExodusPoint Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.3K Sell
13,278
-4,677
-26% -$33.5K ﹤0.01% 1466
2026
Q1 		$120K Sell
17,955
-33,464
-65% -$192K ﹤0.01% 1426
2025
Q4 		$280K Buy
51,419
+7,998
+18% +$47.5K ﹤0.01% 1325
2025
Q3 		$268K Sell
43,421
-129
-0.3% -$844 ﹤0.01% 1329
2025
Q2 		$273K Buy
+43,550
New +$255K ﹤0.01% 1257

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ExodusPoint Capital Management's AURA Position: Q2 2026 in Review

ExodusPoint Capital Management reduced its Aura Biosciences (AURA) stake by 26% in Q2 2026, selling an estimated $33.5K and leaving 13,278 shares worth $94.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1466.

ExodusPoint Capital Management first reported a position in AURA in Q2 2025 and has held it in 5 quarters since. The position peaked at $280K in Q4 2025. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • ExodusPoint Capital Management held 13,278 shares of Aura Biosciences worth $94.3K as of Q2 2026.
  • ExodusPoint Capital Management sold 4,677 Aura Biosciences shares in Q2 2026, an estimated $33.5K.
  • Aura Biosciences made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q2 2026, its #1466 holding.
  • ExodusPoint Capital Management first reported a position in Aura Biosciences in Q2 2025 and has held it in 5 quarters since.
  • ExodusPoint Capital Management's Aura Biosciences position peaked at $280K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.